CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Arch Biopartners Inc Company Snapshot
Arch Biopartners Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arch Biopartners Inc with three other companies in this sector in Canada: Pacgen Life Science Corporation (2015 sales of 59,552.00 Canadian Dollars [US$45,738.91 ] ), Novoheart Holdings Inc (11,876.00 Canadian Dollars [US$9,121.36 ] ), and Promis Neurosciences Inc (19,935.00 Canadian Dollars [US$15,311.08 ] of which 100% was Research and Develo).

Sales Analysis.
   
   
 
  Stock Performance Chart for Arch Biopartners Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/19/2018): 1.46
(Figures in Canadian Dollars)
1 Week 3.5%   13 Weeks -5.2%  
4 Weeks -5.8%   52 Weeks 239.5%  
 
Arch Biopartners Inc Key Data:
  Ticker: ARCH Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 37,641
(Year Ending Jan 2016).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 85,359,161
  Fiscal Yr Ends: September Shares Outstanding: 58,465,179
  Share Type: Closely Held Shares: 18,246,500
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.